Emmes can help you navigate the investigational new drug, device and biologics regulatory pathways toward a successful product launch.

We understand how drug and medical device regulations impact your product regulatory approval timelines. We appreciate your clinical product development challenges, provide proactive guidance to mitigate product development risk with regards to FDA, Health Canada, EMA and other regulations for drugs, biologics and medical devices.

As your partner, we will guide you on regulatory and clinical research study schedule issues, decrease your time-to-market, and increase the likelihood of success with novel approaches to optimize your product’s development schedule. And we’ll support you throughout your product development lifecycle, whether you need regulatory strategy, operational support or regulatory writing assistance.

Our teams are located around the world, including the US, Canada, Europe, and India, and offer expertise in ICH guidelines, country and region specific regulatory submission requirements. We can also support coordinated operational submissions across multiple countries.